These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 19056748)

  • 1. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms.
    Lee CK; Rubin LG; Moldwin RM
    Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.
    del Prado G; Ruiz V; Naves P; Rodríguez-Cerrato V; Soriano F; del Carmen Ponte M
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):311-8. PubMed ID: 20638597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
    Harrison JJ; Turner RJ; Ceri H
    Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm susceptibility to metal toxicity.
    Harrison JJ; Ceri H; Stremick CA; Turner RJ
    Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telavancin: in vitro activity against staphylococci in a biofilm model.
    Gander S; Kinnaird A; Finch R
    J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
    Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
    Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
    Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media.
    Kostenko V; Ceri H; Martinuzzi RJ
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):277-88. PubMed ID: 17727657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
    Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
    FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.